{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:26:45Z","timestamp":1794274005476,"version":"4.9.0"},"reference-count":48,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>To describe the characteristics of individuals undergoing toxicology testing at delivery for a sole indication of cannabis use and to evaluate the rate of unexpected positive toxicology testing results among this cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This retrospective cohort study included dyads with a maternal history of cannabis use who underwent peripartum toxicology testing between 2016 and 2020 at 5 birthing hospitals in Massachusetts. We collected information on maternal demographic characteristics and toxicology test results and reviewed records of dyads with unexpected positive results to identify additional social risk factors and clinical outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Of 60\u2009608 live births reviewed, 1924 dyads underwent toxicology testing, including 614 (31.9%) for a sole indication of cannabis use. Significantly greater percentages of patients in the cannabis cohort were &amp;lt;25 years old (32.4% vs 6.1% of the birthing population, P &amp;lt;.001), non-Hispanic Black (32.4% vs 8.1%, P &amp;lt; .001), Hispanic or Latino (30.5% vs 15.5%), American Indian\/Alaskan (0.7% vs 0.1%), and publicly insured (39.9% vs 15.6%, P &amp;lt;.001). Eight of the 614 dyads (1.3%) had an unexpected positive toxicology test result, including 2 (0.3%) unexpectedly positive for opioids. Seven dyads (1.1%) had false positive test results for unexpected substances. Only 1 test result changed clinical management; a urine test positive for opioids prompted monitoring (but not medication) for neonatal opioid withdrawal syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Toxicology testing of patients for a sole indication of cannabis use, without other risk factors, may be of limited utility in elucidating other substance use and may exacerbate existing disparities in perinatal outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2022-006897","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:09:59Z","timestamp":1677658199000},"page":"317-325","source":"Crossref","is-referenced-by-count":17,"title":["Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use"],"prefix":"10.1542","volume":"13","author":[{"given":"Leela","family":"Sarathy","sequence":"first","affiliation":[{"name":"aDepartments of Pediatrics"},{"name":"bHarvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Chou","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"},{"name":"bHarvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Lerou","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"},{"name":"bHarvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[{"name":"cFriends Research Institute, Baltimore, Maryland"},{"name":"dDepartment of Family and Community Medicine, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Mark","sequence":"additional","affiliation":[{"name":"eDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dorfman","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Wilens","sequence":"additional","affiliation":[{"name":"bHarvard Medical School, Boston, Massachusetts"},{"name":"fPsychiatry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"bHarvard Medical School, Boston, Massachusetts"},{"name":"gObstetrics, Gynecology and Reproductive Biology, Division of Maternal Fetal Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida M.","family":"Schiff","sequence":"additional","affiliation":[{"name":"aDepartments of Pediatrics"},{"name":"bHarvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2023112714000132300_b1","unstructured":"CBHSQ. Results from the 2017 National Survey on Drug Use and Health: detailed tables. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHDetailedTabs2017\/NSDUHDetailedTabs2017.htm. Accessed March 9, 2022"},{"issue":"6","key":"2023112714000132300_b2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ajog.2017.08.015","article-title":"Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged women","volume":"217","author":"Jarlenski","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2023112714000132300_b3","doi-asserted-by":"crossref","first-page":"201.e1","DOI":"10.1016\/j.ajog.2015.03.021","article-title":"Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age","volume":"213","author":"Ko","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2023112714000132300_b4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/ADM.0000000000000299","article-title":"Pregnant women\u2019s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm","volume":"11","author":"Mark","year":"2017","journal-title":"J Addict Med"},{"issue":"5","key":"2023112714000132300_b5","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ajog.2007.10.780","article-title":"Universal screening for substance abuse at the time of parturition","volume":"198","author":"Azadi","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2023112714000132300_b6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/AOG.0000000000004868","article-title":"Umbilical cord collection and drug testing to estimate prenatal substance exposure in Utah","volume":"140","author":"Smid","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2023112714000132300_b7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"2023112714000132300_b8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/fnl.11.27","article-title":"Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain","volume":"6","author":"Wu","year":"2011","journal-title":"Future Neurol"},{"issue":"4","key":"2023112714000132300_b9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/AOG.0000000000001649","article-title":"Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis","volume":"128","author":"Conner","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2023112714000132300_b10","doi-asserted-by":"crossref","first-page":"573.e1","DOI":"10.1016\/j.ajog.2013.08.005","article-title":"Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study","volume":"209","author":"Feinshtein","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"2023112714000132300_b11","first-page":"242","article-title":"Behavioral outcomes in preschool and school-age children exposed prenatally to marijuana: a review and speculative interpretation","volume":"164","author":"Fried","year":"1996","journal-title":"NIDA Res Monogr"},{"issue":"2","key":"2023112714000132300_b12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2019.8734","article-title":"Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes","volume":"322","author":"Corsi","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"2023112714000132300_b13","doi-asserted-by":"crossref","first-page":"e20181889","DOI":"10.1542\/peds.2018-1889","article-title":"Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes","volume":"142","author":"Ryan","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"2023112714000132300_b14","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/AOG.0000000000002354","article-title":"Committee opinion no. 722: Marijuana use during pregnancy and lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2023112714000132300_b15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/AOG.0000000000001343","article-title":"Obstetric health care providers\u2019 counseling responses to pregnant patient disclosures of marijuana use","volume":"127","author":"Holland","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2023112714000132300_b16","doi-asserted-by":"crossref","first-page":"108998","DOI":"10.1016\/j.drugalcdep.2021.108998","article-title":"Pregnant people\u2019s experiences discussing their cannabis use with prenatal care providers in a state with legalized cannabis","volume":"227","author":"Woodruff","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"2023112714000132300_b17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/0269881109348165","article-title":"During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study","volume":"24","author":"Moore","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"2","key":"2023112714000132300_b18","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2023112714000132300_b19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/jp.2013.180","article-title":"Cannabis, the pregnant woman and her child: weeding out the myths","volume":"34","author":"Jaques","year":"2014","journal-title":"J Perinatol"},{"issue":"6","key":"2023112714000132300_b20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1360-0443.2006.01444.x","article-title":"The use of record linkage to examine illicit drug use in pregnancy","volume":"101","author":"Burns","year":"2006","journal-title":"Addiction"},{"issue":"4","key":"2023112714000132300_b21","doi-asserted-by":"crossref","first-page":"100621","DOI":"10.1016\/j.ajogmf.2022.100621","article-title":"Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort","volume":"4","author":"Koenigs","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2023112714000132300_b22","unstructured":"Guttmacher Institute. Substance use during pregnancy. Available at: https:\/\/www.guttmacher.org\/state-policy\/explore\/substance-use-during-pregnancy. Accessed April 3, 2022"},{"issue":"1-3","key":"2023112714000132300_b23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drugalcdep.2010.01.007","article-title":"Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study","volume":"109","author":"van Gelder","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2023112714000132300_b24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/ADM.0000000000000424","article-title":"Characteristics of pregnant women reporting cannabis use disorder at substance use treatment entry","volume":"12","author":"Washio","year":"2018","journal-title":"J Addict Med"},{"issue":"2","key":"2023112714000132300_b25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/pr.2011.25","article-title":"Birth outcomes associated with cannabis use before and during pregnancy","volume":"71","author":"Hayatbakhsh","year":"2012","journal-title":"Pediatr Res"},{"issue":"2","key":"2023112714000132300_b26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2023112714000132300_b27","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2023112714000132300_b28","unstructured":"Marijuana Policy Project (MPP). Massachusetts. Available at: https:\/\/www.mpp.org\/states\/massachusetts\/. Accessed April 3, 2022"},{"issue":"5","key":"2023112714000132300_b29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1542\/peds.2008-1635","article-title":"Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines","volume":"123","author":"Newman","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2023112714000132300_b30","doi-asserted-by":"crossref","first-page":"2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics"},{"issue":"3","key":"2023112714000132300_b31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jpeds.2014.10.004","article-title":"Universal maternal drug testing in a high-prevalence region of prescription opiate abuse","volume":"166","author":"Wexelblatt","year":"2015","journal-title":"J Pediatr"},{"issue":"2","key":"2023112714000132300_b32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/AOG.0000000000004884","article-title":"Test or talk: empiric bias and epistemic injustice","volume":"140","author":"Terplan","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2023112714000132300_b33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/AOG.0b013e31820a6216","article-title":"AGOG committee opinion no. 473: substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2023112714000132300_b34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.whi.2010.02.003","article-title":"Women\u2019s perspectives on screening for alcohol and drug use in prenatal care","volume":"20","author":"Roberts","year":"2010","journal-title":"Womens Health Issues"},{"issue":"3","key":"2023112714000132300_b35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","article-title":"Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care","volume":"15","author":"Roberts","year":"2011","journal-title":"Matern Child Health J"},{"issue":"5","key":"2023112714000132300_b36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.jp.7210933","article-title":"Prenatal care reduces the impact of illicit drug use on perinatal outcomes","volume":"23","author":"El-Mohandes","year":"2003","journal-title":"J Perinatol"},{"issue":"1","key":"2023112714000132300_b37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4278\/ajhp.141215-QUAL-625","article-title":"Perinatal illicit drug and marijuana use: an observational study examining prevalence, screening, and disclosure","volume":"31","author":"Chang","year":"2017","journal-title":"Am J Health Promot"},{"key":"2023112714000132300_b38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ypmed.2017.05.012","article-title":"Cannabis and pregnancy: maternal child health implications during a period of drug policy liberalization","volume":"104","author":"Mark","year":"2017","journal-title":"Prev Med"},{"key":"2023112714000132300_b39","unstructured":"Warde Medical Laboratory. Detection of prenatal drug abuse in meconium. Available at: https:\/\/wardelab.com\/warde-reports\/detection-of-prenatal-drug-abuse-in-meconium\/. Accessed April 7, 2022"},{"key":"2023112714000132300_b40","unstructured":"National Institute on Drug Abuse. Screening for drug use in general medical settings resource guide screening for drug use in general medical settings: a resource guide for providers. Available at: https:\/\/nida.nih.gov\/sites\/default\/files\/resource_guide.pdf. Accessed October 11, 2021"},{"issue":"6","key":"2023112714000132300_b41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.jp.7211266","article-title":"The 4P\u2019s Plus screen for substance use in pregnancy: clinical application and outcomes","volume":"25","author":"Chasnoff","year":"2005","journal-title":"J Perinatol"},{"issue":"3","key":"2023112714000132300_b42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/AOG.0000000000003986","article-title":"Toxicology testing in pregnancy: evaluating the role of social profiling","volume":"136","author":"Perlman","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2023112714000132300_b43","unstructured":"Edwards\u2008E, Bunting\u2008W, Garcia\u2008L. The war on marijuana in black and white. Available at: https:\/\/www.aclu.org\/report\/report-war-marijuana-black-and-white. Accessed January 24, 2022"},{"issue":"5","key":"2023112714000132300_b44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/AOG.0000000000002937","article-title":"Racial and ethnic disparities in the incidence of severe maternal morbidity in the United States, 2012-2015","volume":"132","author":"Admon","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2023112714000132300_b45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0000000000003667","article-title":"Race and ethnicity, medical insurance, and within-hospital severe maternal morbidity disparities","volume":"135","author":"Howell","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"37","key":"2023112714000132300_b46","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.15585\/mmwr.mm6937a1","article-title":"Racial and ethnic disparities in fetal deaths - United States, 2015-2017","volume":"69","author":"Pruitt","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"2023112714000132300_b47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10995-017-2290-3","article-title":"Disparities in infant mortality by race among Hispanic and non-Hispanic infants","volume":"21","author":"Rice","year":"2017","journal-title":"Matern Child Health J"},{"issue":"6","key":"2023112714000132300_b48","doi-asserted-by":"crossref","first-page":"e1596","DOI":"10.1542\/peds.2011-2726","article-title":"Safely doing less: a missing component of the patient safety dialogue","volume":"128","author":"Schroeder","year":"2011","journal-title":"Pediatrics"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/13\/4\/317\/1574785\/hpeds.2022-006897.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/13\/4\/317\/1574785\/hpeds.2022-006897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T14:02:58Z","timestamp":1701093778000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/13\/4\/317\/190788\/Limited-Utility-of-Toxicology-Testing-at-Delivery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2022-006897","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}